| 2021 | Management of Abemaciclib-Associated Adverse Events in Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Safety Analysis of MONARCH 2 and MONARCH 3
| ONCOLOGIST |
| 2020 | Management of Allergic Patients During the COVID-19 Pandemic in Asia
| ALLERGY ASTHMA & IMMUNOLOGY RESEARCH |
| 2023 | Management of antineutrophil cytoplasmic antibody-associated vasculitis: a review of recent guidelines
| Journal of Rheumatic Diseases |
| 2013 | Management of Asymptomatic Erosive Esophagitis: An E-Mail Survey of Physician's Opinions
| GUT AND LIVER |
| 2017 | Management of Clevudine-Resistant Chronic Hepatitis B: A Multicenter Cohort Study
| GUT AND LIVER |
| 2019 | Management of Clinical T1N0M0 Esophageal Cancer
| GUT AND LIVER |
| 2023 | Management of HER2 alterations in non-small cell lung cancer - The past, present, and future | LUNG CANCER |
| 2022 | Management of immune thrombocytopenia: 2022 update of Korean experts recommendations
| BLOOD RESEARCH |
| 2023 | Management of infusion-related reactions (IRRs) in patients receiving amivantamab in the CHRYSALIS study
| LUNG CANCER |
| 2020 | Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement
| LANCET GASTROENTEROLOGY & HEPATOLOGY |
| 2011 | Management of the complications of endoscopic submucosal dissection
| WORLD JOURNAL OF GASTROENTEROLOGY |
| 2019 | Management plans for populations with normal-to-hypertensive blood pressures: risks and benefits of antihypertensive drug treatment in populations previously defined as having high-normal blood pressure
| KOREAN JOURNAL OF INTERNAL MEDICINE |
| 2022 | Managing cardiovascular risk in people living with HIV in Asia - where are we now? | HIV MEDICINE |
| 2008 | Mangafodipir trisodium-enhanced MRI of hepatocellular carcinoma: correlation with histological characteristics | CLINICAL RADIOLOGY |
| 1998 | Manually Crimped NIR Stent의 초기결과
| Korean Circulation Journal (순환기) |
| 2018 | Mapping of lateral pelvic lymph node recurrences in rectal cancer: a radiation oncologist's perspective | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
| 2022 | Margetuximab with retifanlimab as first-line therapy in HER2+/PD-L1+ unresectable or metastatic gastroesophageal adenocarcinoma: MAHOGANY cohort A | ESMO OPEN |
| 2023 | Margin-negative minimally invasive pancreatoduodenectomy following FOLFIRINOX neoadjuvant chemotherapy in invasive intraductal papillary mucinous neoplasm of pancreas: a case report
| Korean Journal of Clinical Oncology(대한임상종양학회지) |
| 2022 | MARIPOSA-2: Randomized phase III study of amivantamab plus lazertinib plus chemotherapy vs chemotherapy alone in EGFRmutant NSCLC after osimertinib failure | ANNALS OF ONCOLOGY |
| 2022 | MARIPOSA: phase 3 study of first-line amivantamab + lazertinib versus osimertinib in EGFR-mutant non-small-cell lung cancer | FUTURE ONCOLOGY |
